ANI製藥 ANIP 深 滬
等待開盤 09-03 09:30:00 美东时间
94.02
+0.520
+0.56%
華盛通- 最 高95.365
- 今 開93.60
- 成交量 19.29万股
- 最 低 93.23
- 昨 收 93.50
- 總市值 20.39亿
- 52周最高 95.365
- 市盈率 靜 --
- 換手率 0.89%
- 52周最低 52.50
- 委 比 87.83%
- 總股本 2168.88万
- 歷史最高 95.365
- 量 比 0.58
- 振 幅 2.28%
- 歷史最低 0.80
- 每 手 1
- 風險率 8.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ANI Pharmaceuticals to Present at Upcoming Investor Conferences
ANI Pharmaceuticals announced that its CEO, Nikhil Lalwani, and executive team will present at two upcoming investor conferences: the H.C. Wainwright Global Investment Conference on September 8 and the Morgan Stanley Global Healthcare Conference on September 9. Both events will be webcast live and available on the company's website for 90 days. ANI is a biopharmaceutical company focused on innovative therapeutics and sustainable growth through it...
08-25 20:30
Adani Ports Launches Logistics Park in Kochi, Boosting Kerala’s Industrial Growth
Adani Ports & Special Economic Zone Ltd ( ($IN:ADANIPORTS) ) has provided a...
08-23 14:45
Earnings Preview For Liquidia
Liquidia (NASDAQ:LQDA) is gearing up to announce its quarterly earnings on Tues...
08-11 23:04
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
ANI Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY5 guidance above estimates.
ANI Pharmaceuticals shares are trading higher after the company reported better...
08-08 20:42
ANI Pharmaceuticals Raises FY2025 Adj EPS Guidance from $6.27-$6.62 to $6.98-$7.35 vs $6.52 Est; Raises FY2025 Sales Guidance from $768M-$793M to $818M-$843M vs $788.076M Est
Full Year 2025 Guidance:Full Year 2025GuidancePrevious Full Year 2025Guidance2024 ActualGrowth Net Revenue (Total Company)$818 million - $843 million$768 million - $793 million$614 million33% - 37%Cortrophin Gel Net
08-08 18:52
Earnings Scheduled For August 8, 2025
Companies Reporting Before The Bell • BeOne Medicines (NASDAQ:ONC) is expected ...
08-08 16:32
ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET
ANI Pharmaceuticals announced the release of its Q2 2025 financial results on August 8, 2025, before the market opens. A conference call at 8:30 a.m. ET, featuring CEO Nikhil Lalwani and other executives, will discuss the results. The call can be accessed via toll-free number 800-343-4136 (ID: 5034065) or webcast on www.anipharmaceuticals.com. A replay will be available within two hours post-call for two weeks.
08-01 10:50
Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update
Anika Therapeutics announced top-line results from its U.S. pivotal trial of Hyalofast, a hyaluronic acid scaffold used for cartilage repair. While Hyalofast showed consistent improvements over microfracture in pain and function measures, it did not meet the pre-specified co-primary endpoints for statistical significance. However, it demonstrated statistically significant improvements in key secondary endpoints and other measures aligned with pri...
07-30 11:00
ANI Pharmaceuticals to Challenge Court Verdict
The latest update is out from ANI Pharmaceuticals ( ($ANIP) ). ANI Pharmaceutic...
07-30 05:22
